“Antiarrhythmic Efficacy and Safety of 1C Class anti­­arrhythmic Agents Ethacizin and Propafenone in Patients With Arterial Hypertension and Frequent Recurrences of Atrial Fibrillation”. Ukrainian Journal of Cardiology, vol. 25, no. 2, May 2018, pp. 43-49, https://ucardioj.com.ua/index.php/UJC/article/view/58.